logo
  1. Home
  2. Stocks
  3. Gland Pharma

Gland Pharma Share Price

Small Cap | Pharmaceuticals and health care | NSE: GLAND | BSE: 543245

₹1,474.85 image-84.65 (-5.43 %)

Last Updated: 04 Apr 2025 03:59 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 1,564.65

High (₹) 1,570.00

Low (₹) 1,463.00

Prev. Close (₹) 1,559.50

Volume 5,15,601

VWAP (₹) 1,562.58

ROCE (%) 12.50

Industry P/E 46.49

TTM P/E 34.50

P/B Ratio 2.78

Market Cap (₹) Cr.24,299.10

Dividend Yield (%)--

EPS (₹) 46.90

ROE8.85%

Sales Growth (%) 56.29

Profit Growth (%)-1.10

Day Range

1,570.001,570.00

L
H

52 Week Range

1,412.002,220.95

L
H

Historical Returns

Returns (6M)

-13.71 %

Returns (1Y)

-15.94 %

Returns (3Y)

-55.78 %

Returns (5Y)

-18.94 %

Returns (6M)

-13.71 %

Returns (1Y)

-15.94 %

Returns (3Y)

-55.78 %

Returns (5Y)

-18.94 %

SWOT Analysis

  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Growth in Net Profit Margin (QoQ)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • High CCI indicates strong upward momentum.
  • Positive ROC (9) indicates upward momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bearish

RSI 55.15

MFI 72.34

ATR 69.16

Commodity Channel Index 104.76

ROC125 -16.02

ROC21 3.08

Williams %R -41.15

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,615.401,678.001,733.601,559.801,497.201,441.601,379.00
Week Ago1,557.851,589.101,610.501,536.451,505.201,483.801,452.55
Month Ago1,534.011,581.781,640.261,475.531,427.761,369.281,321.51

EMA & SMA
info_icon

1474.85

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 1551.59

9 Day 1521.51

10 Day 1513.02

12 Day 1503.39

14 Day 1505.33

20 Day 1510.48

26 Day 1511.08

50 Day 1632.88

100 Day 1677.23

200 Day 1785.37

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy21 Mar, 2025₹1,588.6910,16,219NSE
VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIFbulkBuy21 Mar, 2025₹1,588.698,38,556NSE
NICOMAC MACHINERY PRIVATE LIMITEDbulkSell09 Apr, 2024₹1,735.3119,55,452NSE
LAKUMI TRUSTbulkSell09 Apr, 2024₹1,739.1061,65,486NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell09 Aug, 2023₹1,700.0211,10,300NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy09 Aug, 2023₹1,698.7211,10,300NSE
MORGAN STANLEY INVESTMENT FUNDS EMERGING MARKETS EQUITY FUNDbulkSell22 May, 2023₹930.699,60,271NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
26 Feb, 2025S SREENIVASA RAOAcquisition₹542.002,800NSE
28 Jun, 2024BH LENIN KUMAR RAJADisposal₹1,807.861,400NSE
28 Jun, 2024RONG WUDisposal₹1,788.775,792NSE
28 Jun, 2024P B RAVINDRA VARMADisposal₹1,824.922,000NSE
28 Jun, 2024RONG WUDisposal₹1,820.256,182NSE
28 Jun, 2024SRINIVASA RAO SDisposal₹1,822.001,000NSE
28 Jun, 2024SRINIVASA RAO SDisposal₹1,812.281,950NSE
28 Jun, 2024P B RAVINDRA VARMADisposal₹1,810.001,950NSE
26 Jun, 2024A JAYATHEERTHADisposal₹1,825.00968NSE
26 Jun, 2024K RAGHURAMACHANDRA RAODisposal₹1,825.001,500NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
22 May, 2024Rs.20.0000 per share(2000%)Final Dividend16 Aug, 202416 Aug, 2024

Announcements

DateSourceDetail
03 Apr, 2025BSE IndiaGland Pharma receives approval for Acetaminophen Injection
31 Mar, 2025NSE IndiaGland Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
31 Mar, 2025BSE IndiaPostal Ballot Results - Scrutinizer Report
31 Mar, 2025BSE IndiaPostal Ballot Voting Results
28 Mar, 2025NSE IndiaGLAND PHARMA LIMITED has informed the Exchange about Closure of Trading Window
28 Mar, 2025NSE IndiaGland Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
24 Mar, 2025BSE IndiaSchedule of Analyst/Investor Meet
24 Mar, 2025NSE IndiaGland Pharma Limited has informed the Exchange about Schedule of meet
22 Mar, 2025NSE IndiaGland Pharma Limited has informed the Exchange regarding ''ESOP Scheme 2025''.
11 Mar, 2025BSE IndiaInvestor Call Intimation

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--17 Jan, 202503 Feb, 2025
Quarterly Results--23 Oct, 202404 Nov, 2024
Quarterly Results--22 Jul, 202406 Aug, 2024
Audited Results & Final Dividend--10 May, 202422 May, 2024
Quarterly Results--12 Jan, 202414 Feb, 2024
Quarterly Results--18 Oct, 202306 Nov, 2023
Quarterly Results--28 Jul, 202307 Aug, 2023
Audited Results & A.G.M.--24 May, 202318 May, 2023
Quarterly Results--09 Jan, 202323 Jan, 2023
Quarterly Results--11 Oct, 202226 Oct, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group51.83%57.86%57.86%58%58.36%
Foreign Institutions +5.04%4.05%4.67%11.3%12.73%
Domestic Institutions +34.8%24.17%23.14%11.66%10.81%
Government0%0%0%0%0%
Public8.33%13.92%14.33%19.04%18.1%
Others0%0%0%0%0%

About Gland Pharma

Gland Pharma is a Public Limited Listed company incorporated on 20/03/1978 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1978PLC002276 and registration number is 002276. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 4167.43 Cr. and Equity Capital is Rs. 16.47 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1978

Managing Director

Mr. Srinivas Sadu

NSE Symbol

GLAND

Gland Pharma Management

NameDesignation
Mr. Yiu Kwan Stanley LauChairman & Ind.Director
Mr. Srinivas SaduManaging Director & CEO
Mr. Yao FangNon Executive Director
Dr. Jia Ai (Allen) ZhangNon Executive Director
Mr. Qiyu ChenNon Executive Director
Mr. Essaji Goolam VahanvatiIndependent Director
Mr. Udo Johannes VetterIndependent Director
Mr. Satyanarayana Murthy ChavaliIndependent Director
Ms. Naina Lal KidwaiIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Gland Pharma

What is the share price of Gland Pharma?

The share price of Gland Pharma on 04 Apr, 2025 is ₹ 1,474.85.

What is 52W high and 52W low share price of Gland Pharma?

The highest and lowest 52W share prices of Gland Pharma are ₹ 2220.950 and ₹ 1412.000

What is the market cap of Gland Pharma?

The market capitalization of Gland Pharma as of 04 Apr, 2025 is ₹ 24,299.10 Crores

What is the P/E ratio of Gland Pharma?

The current P/E ratio of Gland Pharma as of 04 Apr, 2025 is 46.49

What is the PB ratio of Gland Pharma?

The PB ratio of Gland Pharma as of 04 Apr, 2025 is 2.78

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited